1-15 of 15 results for subject:Patients
Librarians' tools
- Search time
- 0.179 seconds
- Solr query time
- 0.005 seconds
- Search query
- subject:Patients
- We searched for
- subject_t:Patients OR subject_t:"Sick people" OR subject_ses:92375
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health, what steps his Department is taking to ensure all patients have the opportunity to participate in clinical trials and research.
To ask the Secretary of State for Health, what steps his Department is taking to ensure all patients have the opportunity to participate in clinical trials and research.
The NHS Constitution includes the following pledge: “The NHS commits to inform you of research studies in which you may be eligible to participate”. The Department, via the National Institute for Health Research (NIHR), has a number of initiatives to deliver on the pledge, including the UK Clinical Trials Gateway (https://www.ukctg.nihr.ac.uk/) which is a public website where patients, carers and clinicians can find out about clinical studies current studies underway.
The NIHR runs an annual national campaign called ‘Ok to ask’, to encourage the public to ask their clinician about research participation; more specifically, in 2014, the NIHR launched Join Dementia Research to encourage 100,000 people to volunteer to participate in dementia research by 2020; finally, through the NIHR Clinical Research Networks, last year 618,000 patients were recruited by NHS Providers into clinical trials.
Queen's recommendation signified. Money resolution. Agreed to on division (281 to 227).
Queen's recommendation signified. Money resolution. Agreed to on division (281 to 227).
I beg to move,
That, for the purposes of any Act resulting from the Access to Medical Treatments (Innovation) Bill, it is expedient to authorise the payment out of money provided by Parliament of any increase attributable to the Act in the sums payable under any other Act out of money...
I beg to move,
That, for the purposes of any Act resulting from the Access to Medical Treatments (Innovation) Bill, it is expedient to authorise the payment out of money provided by Parliament of any increase attributable to the Act in the sums payable under any other Act out of money...
The debate on Second Reading raised a large number of issues, which clearly need to be addressed and I have no doubt will be addressed in Committee. We cannot second-guess where that Committee will get to or the shape of any Bill that might subsequently return to the Floor of...
The debate on Second Reading raised a large number of issues, which clearly need to be addressed and I have no doubt will be addressed in Committee. We cannot second-guess where that Committee will get to or the shape of any Bill that might subsequently return to the Floor of...
My hon. Friend makes a good point. That is the premise on which the Bill introduced by Lord Saatchi in the other place earlier in the year in the previous Parliament was predicated. My hon. Friend is right that it is a controversial proposition that fear of litigation for medical...
My hon. Friend makes a good point. That is the premise on which the Bill introduced by Lord Saatchi in the other place earlier in the year in the previous Parliament was predicated. My hon. Friend is right that it is a controversial proposition that fear of litigation for medical...
The hon. Lady makes a series of interesting points. Her criticisms would perhaps apply more to the Bill introduced by Lord Saatchi in the other House. Let me confirm that this Bill has nothing at all to do with clinical research. It is to do with clarifying the freedoms that...
The hon. Lady makes a series of interesting points. Her criticisms would perhaps apply more to the Bill introduced by Lord Saatchi in the other House. Let me confirm that this Bill has nothing at all to do with clinical research. It is to do with clarifying the freedoms that...
I want to make two things absolutely clear. First, this Bill, in law, would have no impact at all on clinical research. We in the Department have been very clear about that. If it in any way changed the basis on which clinical research is regulated, it would be a...
I want to make two things absolutely clear. First, this Bill, in law, would have no impact at all on clinical research. We in the Department have been very clear about that. If it in any way changed the basis on which clinical research is regulated, it would be a...
Yes, indeed; I have listened. I acknowledged those concerns on Second Reading and said I was concerned about them. This is merely a debate about the Bill—there is no change in the law—and it is only this debate that is upsetting people at the moment. It is therefore very important...
Yes, indeed; I have listened. I acknowledged those concerns on Second Reading and said I was concerned about them. This is merely a debate about the Bill—there is no change in the law—and it is only this debate that is upsetting people at the moment. It is therefore very important...
As my hon. Friend knows, I have a lot of respect for his logic and his position, so let me be very clear again. As I tried to explain, I accept that if one were setting out a list of the biggest barriers to the uptake of innovation, fear of...
As my hon. Friend knows, I have a lot of respect for his logic and his position, so let me be very clear again. As I tried to explain, I accept that if one were setting out a list of the biggest barriers to the uptake of innovation, fear of...
The hon. Gentleman will be familiar with the procedures of the House, but I just want to confirm that once the House has given a private Member’s Bill a Second Reading, the convention is that the Government, even when they robustly oppose it, always table a money resolution so that...
The hon. Gentleman will be familiar with the procedures of the House, but I just want to confirm that once the House has given a private Member’s Bill a Second Reading, the convention is that the Government, even when they robustly oppose it, always table a money resolution so that...
It is not for me to defend this private Member’s Bill, promoted by my hon. Friend the Member for Daventry (Chris Heaton-Harris), but I want to deal with two or three points that have been raised in connection with the Government’s view of clinical research and patient safety, both of...
It is not for me to defend this private Member’s Bill, promoted by my hon. Friend the Member for Daventry (Chris Heaton-Harris), but I want to deal with two or three points that have been raised in connection with the Government’s view of clinical research and patient safety, both of...
To ask the Secretary of State for Health, what steps he is taking to increase the number of patients involved in stroke research trials.
To ask the Secretary of State for Health, what steps he is taking to increase the number of patients involved in stroke research trials.
The National Institute for Health Research (NIHR) Clinical Research Network (CRN) makes it possible for patients to participate in relevant research. The CRN supports the set-up and timely delivery of commercial and non-commercial trials and studies in the National Health Service in England. The number of CRN-hosted studies in stroke as main specialty, and recruitment to these studies, has increased substantially since 2008/09.
Data on the number of CRN trials (phases I to IV) and other well-designed studies open in each year in stroke, and recruitment to these trials and studies is shown in the following table.
| 2008/09 | 2009/10 | 2010/11 | 2011/12 | 2012/13 | 2013/14 |
Number of trials | 33 | 47 | 43 | 37 | 35 | 39 |
Number of studies (including trials) | 66 | 98 | 105 | 117 | 115 | 114 |
Recruitment in trials | 2,632 | 3,259 | 4,372 | 5,061 | 4,512 | 3,015 |
Recruitment in studies (including trials) | 6,995 | 7,635 | 10,517 | 11,979 | 12,373 | 9,306 |
Recruitment to stroke studies was lower in 2013/14 than in 2012/13 as several large multi-centre studies with high recruitment targets closed. In addition, there has been change in the overall composition of the stroke study portfolio, with an increased number of single-centre and earlier phase studies with smaller recruitment targets.
I beg to move,
That leave be given to bring in a Bill to allow patients access to and ownership of their own electronic patient records; to require medical professionals to maintain and share electronic patient records as part of individual care plans; and for connected purposes.
Mr Speaker, do you know...
I beg to move,
That leave be given to bring in a Bill to allow patients access to and ownership of their own electronic patient records; to require medical professionals to maintain and share electronic patient records as part of individual care plans; and for connected purposes.
Mr Speaker, do you know...
Ten minute rule motion for leave to bring in a Bill. Agreed to on question. Presentation and first reading (Bill 134). To be read a second time on 17 January 2014.
Ten minute rule motion for leave to bring in a Bill. Agreed to on question. Presentation and first reading (Bill 134). To be read a second time on 17 January 2014.